Cargando…

Relationship Between Hepatitis C Clinical Testing Site and Linkage to Care

BACKGROUND. The Centers for Disease Control and Prevention recommends one-time hepatitis C virus (HCV) testing of the population born between 1945 and 1965 with follow-up RNA testing for those with reactive serology. To increase the rate of diagnosis, testing may be considered in settings other tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assoumou, Sabrina A., Huang, Wei, Horsburgh, C. Robert, Drainoni, Mari-Lynn, Linas, Benjamin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324178/ https://www.ncbi.nlm.nih.gov/pubmed/25734083 http://dx.doi.org/10.1093/ofid/ofu009

Ejemplares similares

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts
por: Yu, Catherine, et al.
Publicado: (2016)

Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City
por: Kamis, Kevin F, et al.
Publicado: (2021)

Low Uptake of Rapid Diagnostic Tests for Respiratory Tract Infections in an Urban Safety Net Hospital
por: Burrowes, Shana A B, et al.
Publicado: (2020)

A Qualitative Study of the Real-world Experiences of Infectious Diseases Fellows Regarding Antibiotic Stewardship
por: Morgan, Jake R, et al.
Publicado: (2018)

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage
por: Bottero, Julie, et al.
Publicado: (2015)

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets
por: Morgan, Jake R, et al.
Publicado: (2017)

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)
por: Metsch, Lisa R, et al.
Publicado: (2021)

Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers
por: Castrejón, Mariana, et al.
Publicado: (2017)

The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons
por: Rajasingham, Radha, et al.
Publicado: (2017)

Hepatitis C Testing Strategies in a Correctional Setting
por: Assoumou, Sabrina A, et al.
Publicado: (2017)

The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
por: Ferrante, Nicole D, et al.
Publicado: (2022)

Primary care provider perceptions and experiences of implementing hepatitis C virus birth cohort testing: a qualitative formative evaluation
por: Yakovchenko, Vera, et al.
Publicado: (2019)

“Community members have more impact on their neighbors than celebrities”: leveraging community partnerships to build COVID-19 vaccine confidence
por: Tjilos, Maria, et al.
Publicado: (2023)

At the intersection of trust and mistrust: A qualitative analysis of motivators and barriers to research participation at a safety‐net hospital
por: Tamlyn, Autumn L., et al.
Publicado: (2023)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes
por: Linas, Benjamin P., et al.
Publicado: (2014)

Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men
por: Baranoski, Amy S., et al.
Publicado: (2015)

CD4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users
por: Anderson, Jeffrey P., et al.
Publicado: (2015)

Risk of HIV Viral Rebound in the Era of Universal Treatment in a Multicenter Sample of Persons With HIV in Primary Care
por: Liu, Tao, et al.
Publicado: (2023)

The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio
por: Brook, Daniel L, et al.
Publicado: (2021)

2570. HCV Screening Practices Among Adolescents and Young Adults in a National Sample of Federally Qualified Health Centers in the United States
por: Epstein, Rachel L, et al.
Publicado: (2018)

Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness
por: Partida, Diana, et al.
Publicado: (2022)

Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021)

Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting
por: Kannan, Ayswarya, et al.
Publicado: (2021)

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C
por: Rowan, Sarah E., et al.
Publicado: (2023)

Anatomic Site–Specific Gonorrhea and Chlamydia Testing and Incidence Among People With HIV Engaged in Care at 4 US Clinical Centers, 2014–2018
por: Menza, Timothy W, et al.
Publicado: (2022)

Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV
por: Cachay, Edward R, et al.
Publicado: (2018)

Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs
por: Chevaliez, Stéphane, et al.
Publicado: (2020)

Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment
por: Ades, A E, et al.
Publicado: (2022)

Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study
por: Conway, Anna, et al.
Publicado: (2023)

Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial
por: Eckhardt, Benjamin, et al.
Publicado: (2022)

Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment
por: Howes, Nik, et al.
Publicado: (2016)

Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department
por: Franco, Ricardo A., et al.
Publicado: (2016)

Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
por: Pollock, Nira R, et al.
Publicado: (2021)

Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus–Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study
por: Kim, H Nina, et al.
Publicado: (2019)

Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
por: Liang, Po-Cheng, et al.
Publicado: (2020)

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care
por: Rossi, Carmine, et al.
Publicado: (2019)

The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
por: Cachay, Edward R., et al.
Publicado: (2015)

Disinfection of Syringes Contaminated With Hepatitis C Virus by Rinsing With Household Products
por: Binka, Mawuena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4h279i96kvko684l3o3hb07r3r